Sale of Biotage's facility in Charlottesville, Virginia
12-Jan-2010
- USA
Sales price of the facility is USD 5,5 million, which results in a smaller loss of approximately USD 0,1 million. Net after transaction costs Biotage's cash holdings increases with approximately USD 1,3 million.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.